Healthcare >> CEO Interviews >> October 12, 2001

Louis Lange – Cv Therapeutics Inc (cvtx)

DR. LOUIS G. LANGE was a Founder of CV Therapeutics Inc. and has served as the Chairman of the Board and Chief Executive Officer since August 1992. From July 1980 to August 1992, Dr. Lange served on the faculty of Washington University School of Medicine, including serving as Chief of Cardiology at Jewish Hospital in St. Louis, Missouri, from May 1985 to August 1992, and as a full Professor of Medicine from July 1990 until August 1992. Dr. Lange is internationally recognized as an expert in the field of molecular mechanisms of cardiovascular disease. He holds an MD from Harvard Medical School and a PhD in Biochemistry from Harvard University. He was recently on the Board of Directors of Cardiac Pathways Corporation and is currently on the Board of Directors, the Executive Committee and is Chair of the Health Affairs Committee at the University of Rochester. He also serves on the Executive Committee of the Biotechnology Industry Organization, as well as the BIO Board of Directors and the Emerging Companies Governing Section. He was recently appointed to the Board of TIMI-3. Profile
TWST: Could you start us off with an overview and summary of what CV

Therapeutics is?

Dr. Lange: What CV Therapeutics has, as you know, as its mission is to

be a leader in the discovery,